Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Experimental Neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11358437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iron, free radicals, and oxidative injury.

  2004cited by this paper
• Developmental cell death in dopaminergic neurons of the substantia nigra of mice

  2000cited by this paper
• A new concept in neurodegeneration: TNFalpha is a silencer of survival signals.

  2000cited by this paper
• Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury.

  1999cited by this paper
• Exacerbation of Damage and Altered NF-κB Activation in Mice Lacking Tumor Necrosis Factor Receptors after Traumatic Brain Injury

  1999cited by this paper
• A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.

  1999cited by this paper
• Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.

  1999cited by this paper
• GDNF Increases the Density of Cells Containing Calbindin but Not of Cells Containing Calretinin in Cultured Rat and Human Fetal Nigral Tissue

  1999cited by this paper
• Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment.

  1999cited by this paper
• FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

  1999cited by this paper
• Oxidative mechanisms in nigral cell death in Parkinson's disease.

  1998cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling.

  1998cited by this paper
• Experimental developments in movement disorders: update on proposed free radical mechanisms.

  1998cited by this paper
• Stimulation of different phospholipase A2 isoforms by TNF-alpha and IL-1beta in adult rat ventricular myocytes.

  1998cited by this paper
• Iron metabolism and Parkinson's disease.

  1998cited by this paper
• Free-radical toxicity and antioxidant medications in Parkinson's disease.

  1998cited by this paper
• TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination

  1998cited by this paper
• Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines.

  1998cited by this paper
• Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

  1997cited by this paper
• Activation of NF‐κB protects hippocampal neurons against oxidative stress‐induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration

  1997cited by this paper
• TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice.

  1997cited by this paper
• Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease.

  1997cited by this paper
• Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

  1997cited by this paper
• Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons.

  1997cited by this paper
• The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra.

  1997cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997cited by this paper
• Neuronal vulnerability in Parkinson's disease.

  1997cited by this paper
• Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia

  1997cited by this paper
• Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.

  1997cited by this paper
• Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro

  1997cited by this paper
• Neurotrophins Protect Cultured Cerebellar Granule Neurons against the Early Phase of Cell Death by a TwoComponent Mechanism

  1997cited by this paper
• Attempts to obtain neuroprotection in Parkinson's disease

  1997cited by this paper
• Tumor necrosis factor-alpha: a neuromodulator in the CNS.

  1997cited by this paper
• Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.

  1996cited by this paper
• Oxidative stress and the pathogenesis of Parkinson's disease

  1996cited by this paper
• Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

  1996cited by this paper
• Free radical activity of melanins and related substances: biochemical and pathobiochemical aspects.

  1996cited by this paper
• Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.

  1996cited by this paper
• Oxidative stress in Parkinson's disease and other neurodegenerative disorders.

  1996cited by this paper
• Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS.

  1996cited by this paper
• The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex.

  1996cited by this paper
• Oxidative Stress and Parkinson's Disease a

  1996cited by this paper
• Ceramide Induces Apoptosis in Cultured Mesencephalic Neurons

  1996cited by this paper
• Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

  1996cited by this paper
• Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients.

  1996cited by this paper
• Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

  1996cited by this paper
• Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury

  1996cited by this paper
• 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat

  1996cited by this paper
• A study on tumor necrosis factor, tumor necrosis factor receptors, and nitric oxide in human fetal glial cultures.

  1995cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA

  1995cited by this paper
• TNF‐α‐ and IFN‐γ‐mediated signal transduction pathways: effects on glial cell gene expression and function

  1995cited by this paper
• TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis.

  1995cited by this paper
• Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease

  1995cited by this paper
• Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

  1995cited by this paper
• Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons

  1995cited by this paper
• TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.

  1995cited by this paper
• Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity.

  1995cited by this paper
• Brain injury and tumor necrosis factors induce calbindin D‐28K in astrocytes: Evidence for a cytoprotective response

  1995cited by this paper
• Ceramide: an intracellular signal for apoptosis.

  1995cited by this paper
• Two tumour necrosis factor receptors: structure and function.

  1995cited by this paper
• Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1995cited by this paper
• Cytokines in neurodegeneration and repair

  1995cited by this paper
• Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

  1994cited by this paper
• The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling.

  1994cited by this paper
• Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures.

  1994cited by this paper
• Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

  1994cited by this paper
• Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha.

  1994cited by this paper
• Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

  1994cited by this paper
• Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis.

  1994cited by this paper
• Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.

  1994cited by this paper
• Signal transduction through the sphingomyelin pathway

  1994cited by this paper
• Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

  1994cited by this paper
• Tumor necrosis factor-alpha expression in ischemic neurons.

  1994cited by this paper
• Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland.

  1993cited by this paper
• Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system.

  1993cited by this paper
• Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity.

  1993cited by this paper
• Does oxidative stress participate in nerve cell death in Parkinson's disease?

  1993cited by this paper
• Are dopaminergic neurons selectively vulnerable to Parkinson's disease?

  1993cited by this paper
• Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor.

  1993cited by this paper
• Two TNF receptors.

  1992cited by this paper
• An introduction to the free radical hypothesis in Parkinson's disease

  1992cited by this paper
• The two different receptors for tumor necrosis factor mediate distinct cellular responses.

  1991cited by this paper
• Expression of tumor necrosis factor alpha in the developing nervous system.

  1991cited by this paper
• Tumor necrosis factor Characterization at the molecular, cellular and in vivo level

  1991cited by this paper
• Identification and characterization of receptors for tumor necrosis factor-alpha in the brain.

  1991cited by this paper
• Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

  1991cited by this paper
• Parkinson's disease: pathophysiology

  1991cited by this paper
• Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro.

  1991cited by this paper
• Cytotoxic mechanism of tumor necrosis factor‐α

  1990cited by this paper
• Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

  1990cited by this paper
• Production of tumor necrosis factor-alpha by microglia and astrocytes in culture.

  1989cited by this paper
• Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation.

  1989cited by this paper

• Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS

  2025cites this paper
• Etanercept, a peripherally restricted TNF inhibitor, enhances cocaine-induced locomotor behaviors in male, but not female, rats.

  2025cites this paper
• Type 3 resistant starch from Canna edulis improves Parkinson's symptoms, including behavioral function and nerve damage, in Parkinson's model rats by regulating the gut-brain axis.

  2025cites this paper
• Bromelain decreases oxidative stress and Neuroinflammation and improves motor function in adult male rats with cerebellar Ataxia induced by 3-acetylpyridine.

  2024cites this paper
• Exploring the Therapeutic Effects of Multifunctional N-Salicylic Acid Tryptamine Derivative against Parkinson’s Disease

  2023cites this paper
• Cytokine activity in Parkinson’s disease

  2023cites this paper
• Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease

  2023cites this paper
• Cerebral Malaria Model Applying Human Brain Organoids

  2023cites this paper
• Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury

  2022cites this paper
• Interleukin-6 and tumor necrosis factor-α attenuate dopamine release in mice fed a high-fat diet, but not medium or low-fat diets

  2022cites this paper
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation

  2022cites this paper
• Bilirubin Prevents the TH+ Dopaminergic Neuron Loss in a Parkinson’s Disease Model by Acting on TNF-α

  2022cites this paper
• The Bioactivities of Phycocyanobilin from Spirulina

  2022cites this paper
• Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases

  2022cites this paper
• Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

  2021cites this paper
• Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease

  2021cites this paper
• Tumor Necrosis Factor Alpha Signaling and Organogenesis

  2021cites this paper
• Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation

  2021cites this paper
• Long-term exposure to 2-amino-3-methylimidazo[4,5-f]quinoline can trigger a potential risk of Parkinson's disease.

  2021cites this paper
• Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.

  2021cites this paper
• Anxiety-like behavior in female mice is modulated by STAT3 signaling in midbrain dopamine neurons.

  2021cites this paper
• Cell-free miRNAs in Parkinson's disease: potential biomarkers that provide new insights into disease pathogenesis.

  2020cites this paper
• [Immunological aspects of Parkinson's disease].

  2020cites this paper
• Neuroinflammation.

  2020cites this paper
• Effects of Cytokines on Nuclear Factor-Kappa B, Cell Viability, and Synaptic Connectivity in a Human Neuronal Cell Line

  2020cites this paper
• The effect of nobiletin on performance of rats in forced swimming and elevated plus maze tests in intranigral lipopolysaccharide rat model of Parkinson's disease

  2020cites this paper
• Immunoinflammatory Aspects of Parkinson’s Disease

  2020cites this paper
• Cell therapy for Parkinson′s disease is coming of age: current challenges and future prospects with a focus on immunomodulation

  2019cites this paper
• Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor

  2019cites this paper
• Neuroprotective effect of tempeh against lipopolysaccharide-induced damage in BV-2 microglial cells

  2019cites this paper
• Inflammation, Infectious Triggers, and Parkinson's Disease

  2019cites this paper
• Acetylcholine suppresses microglial inflammatory response via α7nAChR to protect hippocampal neurons.

  2019cites this paper
• Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention

  2019cites this paper
• Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD

  2019cites this paper
• TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

  2019cites this paper
• Granulocyte Colony Stimulating Factor Enhances Reward Learning through Potentiation of Mesolimbic Dopamine System Function

  2018cites this paper
• Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

  2018cites this paper
• Granulocyte colony stimulating factor enhances reward learning through potentiation of 1 mesolimbic dopamine system function 2 3

  2018cites this paper
• Tumor necrosis factor‐alpha −1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls

  2018cites this paper
• α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis

  2018cites this paper
• In vivo quantification of glial activation in minipigs overexpressing human α‐synuclein

  2018cites this paper
• Maternal Cognitive Impairment Associated with Gestational Diabetes Mellitus—A Review of Potential Contributing Mechanisms

  2018cites this paper
• N,N-disubstituted azines attenuate LPS-mediated neuroinflammation in microglia and neuronal apoptosis via inhibiting MAPK signaling pathways

  2017cites this paper
• Tumor necrosis factor alpha derived from classically activated “M1” macrophages reduces interstitial cell of Cajal numbers

  2017cites this paper
• Ramulus Cinnamomi extract attenuates neuroinflammatory responses via downregulating TLR4/MyD88 signaling pathway in BV2 cells

  2017cites this paper
• Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

  2017cites this paper
• Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60

  2017cites this paper
• Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases

  2016influential citation
• Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways

  2016cites this paper
• Cellular and systemic effects of Parkinson’s disease-related LRRK2 mutations: An investigation of cytoskeletal function and the innate immune system in transgenic mice and human LRRK2 mutation carriers

  2016cites this paper
• Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses.

  2016cites this paper
• Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cells.

  2016cites this paper
• Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.

  2016cites this paper
• Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia

  2016cites this paper
• Role of Tumor Necrosis Factor Alpha (TNF-a) In Hippocampal Neurodegeneration

  2016cites this paper
• PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.

  2016cites this paper
• Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma

  2015cites this paper
• Role of 26S Proteasome and Regulator of G-Protein Signaling 10 in Regulating Neuroinflammation in the Central Nervous System

  2015cites this paper
• Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson’s Disease Model

  2015cites this paper
• Characterisation of novel therapies to mitigate inflammation in retinal degenerations

  2015cites this paper
• TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells.

  2015cites this paper
• Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring

  2015cites this paper
• The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?

  2015cites this paper
• Physiology of RGS10 in Neurons and Immune Cells.

  2015cites this paper
• How microglia kill neurons.

  2015cites this paper
• Effects of Cordycepin on the Microglia-Overactivation-Induced Impairments of Growth and Development of Hippocampal Cultured Neurons

  2015cites this paper
• Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma

  2015cites this paper
• Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures

  2015cites this paper
• Neuroimmune mechanisms of alcohol and drug addiction.

  2014cites this paper
• Tumor necrosis factor-alpha during neonatal brain development affects anxiety- and depression-related behaviors in adult male and female mice.

  2014cites this paper
• Microglial TNF‐α mediates enhancement of dopaminergic degeneration by brain angiotensin

  2014influential citation
• Autophagy and apoptosis dysfunction in neurodegenerative disorders.

  2014cites this paper
• Cortisol, cytokines, and hippocampal volume interactions in the elderly

  2014cites this paper
• Resveratrol Protects Cortical Neurons against Microglia‐mediated Neuroinflammation

  2013cites this paper
• Tear levels of tumor necrosis factor-alpha in patients with Parkinson's disease.

  2013cites this paper
• Parkinson's disease and oxidative stress: evaluation by BAP and d- ROMs tests

  2013cites this paper
• Dichlorvos‐induced cell cycle arrest and DNA damage repair activation in primary rat microglial cells

  2013cites this paper
• The Role of Innate and Adaptive Immunity in Parkinson's Disease

  2013influential citation
• Inhibition of LPS-Induced Retinal Microglia Activation by Naloxone Does Not Prevent Photoreceptor Death

  2013cites this paper
• Autophagic Impairment Contributes to Systemic Inflammation-Induced Dopaminergic Neuron Loss in the Midbrain

  2013cites this paper
• Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

  2013cites this paper
• Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

  2013cites this paper
• Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population.

  2013cites this paper
• Effects of C-phycocyanin and Spirulina on Salicylate-Induced Tinnitus, Expression of NMDA Receptor and Inflammatory Genes

  2013cites this paper
• Rosiglitazone Protects Dopaminergic Neurons Against Lipopolysaccharide-Induced Neurotoxicity Through Inhibition of Microglia Activation

  2012cites this paper
• Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.

  2012cites this paper
• Neurodegeneration by activated microglia across a nanofiltration membrane

  2012cites this paper
• RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells

  2012cites this paper
• Hypoactivity of the central dopaminergic system and autistic‐like behavior induced by a single early prenatal exposure to lipopolysaccharide

  2012cites this paper
• A substituted 3,4-dihydropyrimidinone derivative (compound D22) prevents inflammation mediated neurotoxicity; role in microglial activation in BV-2 cells.

  2012cites this paper
• Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.

  2012cites this paper
• Beneficial effects of blueberries in experimental autoimmune encephalomyelitis.

  2012cites this paper
• Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse

  2012cites this paper
• Spirulina and C-phycocyanin reduce cytotoxicity and inflammation-related genes expression of microglial cells

  2012cites this paper
• Pharmaceutical perspectives for the delivery of TNF-α in cancer therapy

  2012cites this paper
• Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons

  2012cites this paper
• Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation

  2012influential citation
• Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration

  2012cites this paper
• Regulator of G-Protein Signaling-10 Negatively Regulates NF-κB in Microglia and Neuroprotects Dopaminergic Neurons in Hemiparkinsonian Rats

  2011cites this paper
• Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice.

  2011cites this paper